NeoRecormon® Type of group
Sponsors
PRODUCTOS ROCHE Q.F.S.A.,
Unknown Phase
Multicenter open study to investigate the safety of Weekly therapy with NeoRecormon in patients with low-grade non-Hodgkin´s lymphoma, chronic lymphocytic leukemia or Multiple Myeloma.
Active, not recruitingPER-022-04
Target: 10Updated: 2023-09-04
Multicenter open study to investigate the safety of weekly therapy with Neorecormon in anemic patients with malignant solid tumors.
Active, not recruitingPER-042-04
Target: 10Updated: 2023-09-04